The Home Depot, Inc.
—- Market cap
- —
- Debt
- +$51.31B
- Cash
- −$1.39B
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $24.37B · View financials
Decision snapshot: HD stock price vs WST: inconclusive — current versus $725.60 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at WST's multiple
Implied fair value · at HD's multiple
Needs HD P/E.
Snapshot Sep 11, 2026, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Nine period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
The Home Depot, Inc. · implied price per share
Bear
$86.60
Base
$109.07
Bull
$140.31
WEST PHARMACEUTICAL SERVICES, INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
LOWES COMPANIES INC
HD vs LOW
FASTENAL CO
HD vs FAST
W.W. GRAINGER, INC.
HD vs GWW
STANLEY BLACK & DECKER, INC.
HD vs SWK
WHIRLPOOL CORP /DE/
HD vs WHR
TRACTOR SUPPLY CO /DE/
HD vs TSCO
APTARGROUP, INC.
HD vs ATR
BECTON DICKINSON & CO
HD vs BDX
ICU MEDICAL INC/DE
HD vs ICUI
TELEFLEX INC
HD vs TFX
BAXTER INTERNATIONAL INC
HD vs BAX
CARDINAL HEALTH INC
HD vs CAH
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe HD can sustain its strong ROIC and defend margins while re-rating toward WST-like multiples, then HD looks attractive because it trades at a large discount to WST on P/E, P/S, and EV/EBITDA despite superior scale and higher ROIC.
On a P/E basis, HD trades at 23.9x versus WST at 51.2x, and the stated implied price for HD is 114.5% above the current price. That gap is supported by lower P/S, EV/EBITDA, and EV/Revenue multiples for HD, but the discount is partly explained by WST’s faster growth and richer profitability profile.
Supporting Metrics